Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?

Paulius Bosas, Gintaras Zaleskis, Vita Pasukoniene, Feliksas Jankevicius
2020 Journal of Translational Medicine  
doi:10.1186/s12967-020-02496-5 pmid:32873304 fatcat:yw6qhhvuhra6jlp4tzcxsunofm